Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer
-
Published:2021-06-29
Issue:8
Volume:26
Page:1353-1419
-
ISSN:1341-9625
-
Container-title:International Journal of Clinical Oncology
-
language:en
-
Short-container-title:Int J Clin Oncol
Author:
Tomita NaohiroORCID, Ishida Hideyuki, Tanakaya Kohji, Yamaguchi Tatsuro, Kumamoto Kensuke, Tanaka Toshiaki, Hinoi Takao, Miyakura Yasuyuki, Hasegawa Hirotoshi, Takayama Tetsuji, Ishikawa Hideki, Nakajima Takeshi, Chino Akiko, Shimodaira Hideki, Hirasawa Akira, Nakayama Yoshiko, Sekine Shigeki, Tamura Kazuo, Akagi Kiwamu, Kawasaki Yuko, Kobayashi Hirotoshi, Arai Masami, Itabashi Michio, Hashiguchi Yojiro, Sugihara Kenichi, Tomita Naohiro, Ishida Hideyuki, Tanakaya Koji, Yamaguchi Tatsuro, Kumamoto Kensuke, Tanaka Toshiaki, Hinoi Takao, Miyakura Yasuyuki, Hasegawa Hirotoshi, Ishikawa Hideki, Nakajima Takeshi, Chino Akiko, Sekine Shigeki, Tamura Kazuo, Akagi Kiwamu, Kobayashi Hirotoshi, Arai Masami, Itabashi Michio, Hashiguchi Yojiro, Sugihara Kenichi,
Abstract
AbstractHereditary colorectal cancer (HCRC) accounts for < 5% of all colorectal cancer cases. Some of the unique characteristics commonly encountered in HCRC cases include early age of onset, synchronous/metachronous cancer occurrence, and multiple cancers in other organs. These characteristics necessitate different management approaches, including diagnosis, treatment or surveillance, from sporadic colorectal cancer management. There are two representative HCRC, named familial adenomatous polyposis and Lynch syndrome. Other than these two HCRC syndromes, related disorders have also been reported. Several guidelines for hereditary disorders have already been published worldwide. In Japan, the first guideline for HCRC was prepared by the Japanese Society for Cancer of the Colon and Rectum (JSCCR), published in 2012 and revised in 2016. This revised version of the guideline was immediately translated into English and published in 2017. Since then, several new findings and novel disease concepts related to HCRC have been discovered. The currently diagnosed HCRC rate in daily clinical practice is relatively low; however, this is predicted to increase in the era of cancer genomic medicine, with the advancement of cancer multi-gene panel testing or whole genome testing, among others. Under these circumstances, the JSCCR guidelines 2020 for HCRC were prepared by consensus among members of the JSCCR HCRC Guideline Committee, based on a careful review of the evidence retrieved from literature searches, and considering the medical health insurance system and actual clinical practice settings in Japan. Herein, we present the English version of the JSCCR guidelines 2020 for HCRC.
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Reference307 articles.
1. Japanese Society for the Cancer of the Colon and Rectum (2019) JSCCR guidelines 2019 for the treatment of colorectal cancer. Kanehara & Co. Ltd, Tokyo 2. Jaeschke R, Guyatt GH, Dellinger P et al (2008) GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ 337:a744 3. Lichtenstein P, Holm NV, Verkasalo PK et al (2000) Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85 4. De Rosa M, Pace U, Rega D et al (2015) Genetics, diagnosis and management of colorectal cancer (review). Oncol Rep 34:1087–1096 5. Macaron C, Leach BH, Burke CA (2015) Hereditary colorectal cancer syndromes and genetic testing. J Surg Oncol 111:103–111
Cited by
96 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|